Fifth Affiliated Hospital of Guangzhou Medical University
Fifth Affiliated Hospital of Guangzhou Medical University
Explore linked clinical trials.17 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Feasibility of Multi-cancer Early Detection Test in Screening Population (NQMD-CS) | Digestive System Diseases, Digestive System Neoplasms, Esophageal Neoplasms, Head and Neck Neoplasms, Liver Neoplasms, Neoplasms by Site, Thoracic Neoplasms, colonic disorder, colorectal cancer, colorectal neoplasm, digestive system disorder, digestive system neoplasm, esophageal cancer, esophageal disorder, intestinal disorder, liver cancer, liver disorder, lung cancer, lung disorder, lung neoplasm, neoplasm, rectal disorder, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Not applicable | 2026-09-22 | NCT07834268 | |
| Zanubrutinib Plus Rituximab as Front-line Treatment for Mucosa-associated Lymphoid Tissue Lymphoma (MALT) | B-cell neoplasm, Hemic and Lymphatic Diseases, Lymphoma, B-Cell, Marginal Zone, Neoplasms by Histologic Type, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Active, not recruiting | Phase 2 | 2026-09-15 | NCT06647732 | |
| Early Prophylactic Aspirin for Aneurysmal Subarachnoid Hemorrhage | Hemorrhage, Intracranial Hemorrhages, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, cardiovascular disorder, central nervous system disorder, cerebrovascular disorder, nervous system disorder, subarachnoid hemorrhage, vascular disorder | Not yet recruiting | Phase 4 | 2026-06-11 | NCT07642427 | |
| A Retrospective Study on Clinical Characteristics and Outcomes of Patients With Pneumonia | Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Not yet recruiting | Not stated | 2026-05-08 | NCT07574866 | |
| Research Plan for Early Disease Screening Biomarkers in Healthy Individuals | Health | Not yet recruiting | Not stated | 2026-05-06 | NCT07569094 | |
| A Prospective Observational Cohort Study Protocol for Disease Severity Stratification and Prognosis Assessment in Patients With Pneumonia | Infections, lung disorder, pneumonia, respiratory system disorder, respiratory tract infectious disorder | Not yet recruiting | Not stated | 2026-05-05 | NCT07567911 | |
| Relmacabtagene Autoleucel Combined With Sintilimab for Relapsed/Refractory B-cell Lymphoma | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, follicular lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mantle cell lymphoma, neoplasm | Recruiting | Phase 2 | 2026-01-21 | NCT07077512 | |
| Differentiation of Benign and Malignant Pulmonary Nodules by Volatile Organic Compounds in Human Exhaled Breath | Multiple Pulmonary Nodules, Neoplasms by Site, Thoracic Neoplasms, lung cancer, lung disorder, lung neoplasm, neoplasm, pulmonary coin lesion, respiratory system disorder, respiratory tract neoplasm | Recruiting | Not stated | 2025-12-24 | NCT06518655 | |
| Metformin Hydrochloride and Empagliflozin Tablets in the Treatment of Type 2 Diabetes | Nutritional and Metabolic Diseases, diabetes mellitus, endocrine system disorder, glucose metabolism disease, metabolic disease, type 2 diabetes mellitus | Active, not recruiting | Not stated | 2025-06-04 | NCT07003191 | |
| Identification of Multiple Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath | Actinomycetales infectious disease, Bacterial Infections and Mycoses, Chronic Disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Disease Attributes, Embolism, Embolism and Thrombosis, Fibrosis, Hypersensitivity, Immediate, Infant, Newborn, Diseases, Infections, Lung Injury, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Respiratory Hypersensitivity, Suppuration, Thoracic Injuries, Thoracic Neoplasms, abscess, asthma, bacterial infectious disease, bronchial disorder, bronchiectasis, bronchitis, cardiovascular disorder, chronic obstructive pulmonary disease, cystic fibrosis, gram-positive bacterial infections, hereditary disease, immune system disorder, injury, interstitial lung disease, lung abscess, lung cancer, lung disorder, lung neoplasm, mycobacterial infectious disease, neoplasm, obstructive lung disease, pancreas disorder, pulmonary arterial hypertension, pulmonary embolism, pulmonary emphysema, pulmonary fibrosis, pulmonary hypertension, pulmonary tuberculosis, respiratory system disorder, respiratory tract infectious disorder, respiratory tract neoplasm, tuberculosis, vascular disorder | Recruiting | Not stated | 2025-03-26 | NCT06528418 | |
| Efficacy and Safety of Zuberitamab Combined with Bendamustine, Followed by Monotherapy Maintenance, in Treatment-naïve Follicular Lymphoma | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, follicular lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Not yet recruiting | Phase 2 | 2025-01-03 | NCT06757894 | |
| Induced Pluripotent Stem Cells Derived Natural Killer Cells Therapy for Refractory and Relaps Acute Myelogenous Leukemia | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm | Not yet recruiting | Early phase 1 | 2024-11-22 | NCT06702098 | |
| Surgery Alone Verus Sugery Combined with Dose-reduced Radiotherapy for Newly Diagnosed Stage I Nasopharyngeal Carcinoma | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, carcinoma, epithelial neoplasm, nasopharyngeal carcinoma, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic disease | Recruiting | Not applicable | 2024-11-14 | NCT06688760 | |
| Orelabrutinib in Combination with R-CHOP for CD5-positive DLBCL Patients（Rocket Trial） | B-cell neoplasm, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, diffuse large B-cell lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm | Recruiting | Phase 2 | 2024-10-22 | NCT06647940 | |
| Endoscopic Surgery vs. Intensity Modulated Radiotherapy for Stage I Nasopharyngeal Carcinoma. | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, carcinoma, epithelial neoplasm, nasopharyngeal carcinoma, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic disease | Recruiting | Not applicable | 2024-08-01 | NCT06533267 | |
| Surgery Plus Reduced Target Chemoradiotherapy vs Surgery Plus Reduced Dose Chemoradiotherapy for Newly Diagnosed Operable Nasopharyngeal Carcinoma. | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, carcinoma, epithelial neoplasm, nasopharyngeal carcinoma, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic disease | Recruiting | Not applicable | 2024-07-31 | NCT06529562 | |
| Reduced-target Resection After Induction Chemotherapy in Resectable Recurrent Nasopharyngeal Carcinoma | Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Otorhinolaryngologic Neoplasms, Pharyngeal Diseases, Stomatognathic Diseases, carcinoma, epithelial neoplasm, nasopharyngeal carcinoma, nasopharyngeal disorder, nasopharyngeal neoplasm, neoplasm, otorhinolaryngologic disease | Recruiting | Phase 3 | 2023-05-26 | NCT05877872 |